Year To Quarter End Consolidated Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7718741

Concept 2018-04-01 to
2018-09-30
2017-04-01 to
2017-09-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
57,236,000,000 JPY
54,588,000,000 JPY
Cost of sales
28,923,000,000 JPY
26,589,000,000 JPY
Gross profit (loss)
28,312,000,000 JPY
27,998,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
2,031,000,000 JPY
1,992,000,000 JPY
Bonuses
1,491,000,000 JPY
1,519,000,000 JPY
Selling, general and administrative expenses
20,687,000,000 JPY
19,909,000,000 JPY
Operating profit (loss)
7,622,000,000 JPY
8,089,000,000 JPY
Non-operating income
Interest income
1,000,000 JPY
1,000,000 JPY
Dividend income
125,000,000 JPY
108,000,000 JPY
Non-operating income
197,000,000 JPY
190,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
2,000,000 JPY
Non-operating expenses
64,000,000 JPY
13,000,000 JPY
Ordinary profit (loss)
7,756,000,000 JPY
8,266,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
JPY
Extraordinary income
1,557,000,000 JPY
JPY
Extraordinary losses
Extraordinary losses
7,000,000 JPY
24,000,000 JPY
Profit (loss) before income taxes
9,306,000,000 JPY
8,242,000,000 JPY
Income taxes
2,369,000,000 JPY
2,319,000,000 JPY
Profit (loss)
6,936,000,000 JPY
5,922,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
6,936,000,000 JPY
5,922,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
3,122,000,000 JPY
552,000,000 JPY
Remeasurements of defined benefit plans, net of tax
32,000,000 JPY
72,000,000 JPY
Other comprehensive income
3,154,000,000 JPY
625,000,000 JPY
Comprehensive income
10,091,000,000 JPY
6,547,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
10,091,000,000 JPY
6,547,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.